COST-EFFECTIVENESS ANALYSIS OF AUGMENTIN 625 MG AND AUCLANITYL 500 MG/125 MG IN THE TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA. YHCĐ [Internet]. 2026 Sept. 25 [cited 2026 Nov. 5];67(CD15). Available from: https://tapchiyhcd.vn/index.php/yhcd/article/view/6792